Ohio Legislature (healthcare bills) · May 5, 2026 · Primary source
OH SB 434: Enact the Verified Opioid and Intoxicant Consumer Ed (VOICE) Act
Summary
Ohio SB 434, the Verified Opioid and Intoxicant Consumer Education (VOICE) Act, would enact section 3719.051 requiring that addiction-related educational materials be provided when dispensing opioid analgesics and benzodiazepines. The bill was introduced and is categorized under health and substance abuse/addiction. No details are provided on the content, format, or distribution mechanism of the educational materials. The legislation targets prescribers and dispensers of controlled substances in Ohio.
What this may mean
Pharmacies, hospitals, and prescribers dispensing opioids or benzodiazepines in Ohio may be required to provide standardized patient education materials at the point of dispensing. Compliance teams should monitor for final text detailing materials sourcing, documentation requirements, and penalties. This aligns with broader opioid stewardship and informed consent trends and could affect pharmacy workflows and EMR configurations.
Informational only. Not legal, medical, financial, or other professional advice. Always consult a qualified professional familiar with your specific facts before relying on any item.
Related items
- Federal Register: DEA Diversion Decisions · June 9, 2026Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted TreatmentScore 100
- Kentucky Legislature (healthcare bills) · May 22, 2026KY HB 153: AN ACT relating to administrative regulations for medications for substance use disorder and declaring an emergency.Score 90
- California Medicaid Fraud Control Unit · May 4, 2026Attorney General Bonta Announces $7.4 Billion Purdue Pharma and Sackler Family Opioid Settlement Now in EffectScore 90
- FDA Press Announcements · June 16, 2026FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid OverdoseScore 86
- SAMHSA News · August 17, 2026HHS Awards Over $96 Million to Strengthen Mental Health, Suicide Prevention, and Substance Use Disorder ServicesScore 76
- Kentucky Legislature (healthcare bills) · May 4, 2026KY SB 77: AN ACT relating to ibogaine research in the Commonwealth.Score 76